AI assistant
Comvita Limited — Director's Dealing 2017
Jun 22, 2017
66182_rns_2017-06-22_556e6fb2-f963-4e4b-8baf-32159062fd77.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [91 x 25] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:
==> picture [135 x 84] intentionally omitted <==
Comvita Limited 22 June 2017 26 May 2017
Director or senior manager giving disclosure
Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Nature of the affected relevant interest(s):
For that relevant interest-
Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): Registered holder(s) once transfers are registered:
Alan John Bougen Comvita Limited n/a Company Director
Ordinary Shares Joint registered holder and beneficial owner. 2,004,249 2,009,249 Alan John Bougen, Lynda Ann Bougen and Graeme William Elvin as Trustees of Flaxmill Trust Alan John Bougen, Lynda Ann Bougen and Graeme William Elvin as Trustees of Flaxmill Trust
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
1 15-Jun-17 Purchase of 5,000 shares on market n/a $26,000 1
No n/a n/a
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:
==> picture [64 x 16] intentionally omitted <==
22-Jun-17